Search

Author/Creator Teppler, Hedy

1. 1617Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study. (December 2014)

Authors:
Teppler, Hedy; Shuldyakov, Andrey; Gankina, Natalia; Kulagin, Valeriy; Nagimova, Firaya; Shimonova, Tatiana; Sonin, Dmitriy; Sotnikov, Vladimir; Zakharova, Natalia; Homony, Brenda; Wang, Deng; Moshkovich, Grigoriy
Journal:
Open forum infectious diseases
Issue:
Volume 1(2014)Supplement 1
Page Start:
S431
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 543. An Integrated Safety Analysis Comparing Once-Daily Doravirine (DOR) to Darunavir+Ritonavir (DRV+r) and Efavirenz (EFV) in HIV-1-Infected, Antiretroviral Therapy (ART)-Naïve Adults. (26th November 2018)

Authors:
Thompson, Melanie; Orkin, Chloe; Molina, Jean-Michel; Gatell, Jose; Sax, Paul; Cahn, Pedro; Squires, Kathleen; Zhou, Yan; Xu, Xia; Rodgers, Anthony; Kumar, Sushma; Teppler, Hedy; Martin, Elizabeth; Hanna, George; Hwang, Carey
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S201
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use. Issue 1 (21st October 2021)

Authors:
Mills, Alexander; Myers, Laurie; Raudenbush, Casey; Vossen, David A.; Teppler, Hedy; Miteva, Yanna R.; Seeley, Suzanne; Homony, Brenda; Straus, Walter L.
Journal:
Pediatric infectious disease journal
Issue:
Volume 41:Issue 1(2022)
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use. Issue 1 (January 2022)

Authors:
Mills, Alexander; Myers, Laurie; Raudenbush, Casey; Vossen, David A.; Teppler, Hedy; Miteva, Yanna R.; Seeley, Suzanne; Homony, Brenda; Straus, Walter L.
Journal:
Pediatric infectious disease journal
Issue:
Volume 41:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Association between First-Year Virological Response to Raltegravir and Long-Term Outcomes in Treatment-Experienced Patients with HIV-1 Infection. Issue 3 (April 2015)

Authors:
Eron, Joseph J; Cooper, David A; Steigbigel, Roy T; Clotet, Bonaventura; Yeni, Patrick; Strohmaier, Kim M; Rodgers, Anthony J; Barnard, Richard J; Nguyen, Bach-Yen T; Teppler, Hedy
Journal:
Antiviral therapy
Issue:
Volume 20:Issue 3(2015)
Page Start:
307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis. Issue 2 (February 2015)

Authors:
Boyd, Mark A; Moore, Cecilia L; Molina, Jean-Michel; Wood, Robin; Madero, Juan S; Wolff, Marcelo; Ruxrungtham, Kiat; Losso, Marcelo; Renjifo, Boris; Teppler, Hedy; Kelleher, Anthony D; Amin, Janaki; Emery, Sean; Cooper, David A
Journal:
Lancet
Issue:
Volume 2:Issue 2(2015)
Page Start:
e42
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Doravirine dose Selection and 96-Week Safety and Efficacy versus Efavirenz in Antiretroviral Therapy-Naive Adults with HIV-1 Infection in a Phase IIb Trial. Issue 6 (August 2019)

Authors:
Gatell, Jose M; Morales-Ramirez, Javier O; Hagins, Debbie P; Thompson, Melanie; Arastéh, Keikawus; Hoffmann, Christian; Raffi, François; Osiyemi, Olayemi; Dretler, Robin; Harvey, Charlotte; Xu, Xia; Plettenberg, Andreas; Smith, Don E; Portilla, Joaquín; Rugina, Sorin; Kumar, Sushma; Frobose, Coll...
Journal:
Antiviral therapy
Issue:
Volume 24:Issue 6(2019)
Page Start:
425
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial. (18th December 2020)

Authors:
Orkin, Chloe; Squires, Kathleen E; Molina, Jean-Michel; Sax, Paul E; Sussmann, Otto; Lin, Gina; Kumar, Sushma; Hanna, George J; Hwang, Carey; Martin, Elizabeth; Teppler, Hedy
Journal:
Clinical infectious diseases
Issue:
Volume 73:Number 1(2021)
Page Start:
33
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine. (1st April 2021)

Authors:
Nelson, Mark; Winston, Alan; Hill, Andrew; Mngqibisa, Rosie; Bassa, Ayesha; Orkin, Chloe; Rassool, Mohammed; Rodgers, Anthony; Teal, Valerie; Kumar, Sushma; Teppler, Hedy
Journal:
AIDS
Issue:
Volume 35:Number 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Ertapenem Once a Day Versus Piperacillin–Tazobactam Every 6 Hours for Treatment of Acute Pelvic Infections: A Prospective, Multicenter, Randomized, Double-Blind Study. Issue 1 (2003)

Authors:
Roy, Subir; Higareda, Iliana; Angel-Muller, Edith; Ismail, Mahmoud; Hague, Caren; Adeyi, Ben; Woods, Gail L.; Teppler, Hedy
Journal:
Infectious diseases in obstetrics and gynecology
Issue:
Volume 11:Issue 1(2003)
Page Start:
27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗